Opendata, web and dolomites

TheLiRep

Exploring the Potential for Therapeutic Lineage Reprogramming of Diabetes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TheLiRep project word cloud

Explore the words cloud of the TheLiRep project. It provides you a very rough idea of what is the project "TheLiRep" about.

attractive    embryonic    sources    temporarily    lineage    fate    adult    organ    patients    reprogramming    disease    hyperglycemia    clinical    led    glucostasis    converts    cell    possibly    intellectual    poc    persons    beta    cellular    cells    stem    insulin    type    human    strategy    expression    therapeutic    elaborating    conversion    million    liver    bridge    diabetic    therapy    property    hepatopancreatic    physiological    marketable    either    hypoglycemia    restore    remedy    producing    molecular    ectopic    gap    shortage    grant    idea    treating    developmental    exploited    solid    dysfunction    full    worldwide    types    unable    starting    conceivable    suitable    functional    dangers    explored    despite    350    degenerative    plasticity    pancreatic    serious    earliest    identification    replacement    autologous    proof    diabetes    mechanisms    innovation    option    transplantation    erc    stage    destruction    acute    treatment    pancreas    convert    underlying    thelirep    complications    mouse    centers   

Project "TheLiRep" data sheet

The following table provides information about the project.

Coordinator
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC) 

Organization address
address: ROBERT ROSSLE STRASSE 10
city: BERLIN
postcode: 13125
website: www.mdc-berlin.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2016-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC) DE (BERLIN) coordinator 150˙000.00

Map

 Project objective

Diabetes is a degenerative disease that affects over 350 million persons worldwide. Type 1 and type 2 diabetes are associated with either destruction or dysfunction of pancreatic insulin-producing β cells. Despite the availability of insulin as treatment to temporarily restore the glucostasis, this remedy is unable to avoid either the acute dangers of hypoglycemia or the long-term complications of hyperglycemia. Eventually, the challenge of treating diabetes centers on the replacement of pancreatic β cells. Due to serious organ shortage for pancreas transplantation, cell-based therapy represents the most promising option and different potential sources for new β cells are currently being explored, including embryonic stem cells and other cell types. A particularly attractive therapeutic strategy is to convert liver adult cells of diabetic patients into functional pancreatic β cells through lineage reprogramming. Fate conversion of liver to pancreas is conceivable for numerous physiological and developmental reasons, and, possibly, suitable for future clinical applications. My ERC-funded project (ERC Starting Grant “HEPATOPANCREATIC”) is focused on the molecular mechanisms underlying cellular plasticity between liver and pancreatic cells. This study has led to the identification of a novel factor, whose ectopic expression converts mouse liver cells into pancreatic cells. Here, we propose a defined and focused set of measures aimed at: 1) extending these findings in human liver cells to assess whether this strategy may be exploited to develop an autologous cell-based therapy of diabetes; and 2) elaborating a solid intellectual property strategy. The “TheLiRep” Proof of Concept (PoC) funding will ensure the full exploitation of the ERC idea and bridge the gap between my research and the earliest stage of a marketable innovation.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "THELIREP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "THELIREP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

DISINTEGRATION (2019)

The Mass Politics of Disintegration

Read More  

PROGRESS (2019)

The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

DigitalValues (2019)

The Construction of Values in Digital Spheres

Read More